Cerenome (CNSY) EPS (Diluted) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EPS (Diluted) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 8.02% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -4.52% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 89.89% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 144.25% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 315.14% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -11.18% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 96.41% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -1,017.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,017.01% |
| Mar 31, 2026 | 85.09% |
| Dec 31, 2025 | 85.51% |
| Sep 30, 2025 | 84.11% |
| Jun 30, 2025 | 101.67% |
| Mar 31, 2025 | 62.85% |
| Dec 31, 2024 | 58.22% |
| Sep 30, 2024 | 51.79% |
| Jun 30, 2024 | 42.36% |
| Mar 31, 2024 | -446.49% |
| Dec 31, 2023 | -467.70% |
| Sep 30, 2023 | -422.07% |
| Jun 30, 2023 | -147.94% |
| Mar 31, 2023 | 27.91% |
| Dec 31, 2022 | 37.86% |
| Sep 30, 2022 | 31.95% |
| Jun 30, 2022 | 3.90% |
| Mar 31, 2022 | -44.19% |
| Dec 31, 2021 | -96.46% |
| Sep 30, 2021 | -233.15% |